282 related articles for article (PubMed ID: 29686676)
1. Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance
Comi M; Amodio G; Gregori S
Front Immunol; 2018; 9():682. PubMed ID: 29686676
[TBL] [Abstract][Full Text] [Related]
2. APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells.
Pellerin L; Chen P; Gregori S; Hernandez-Hoyos G; Bacchetta R; Roncarolo MG
Front Immunol; 2018; 9():881. PubMed ID: 29887861
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.
Passeri L; Andolfi G; Bassi V; Russo F; Giacomini G; Laudisa C; Marrocco I; Cesana L; Di Stefano M; Fanti L; Sgaramella P; Vitale S; Ziparo C; Auricchio R; Barera G; Di Nardo G; Troncone R; Gianfrani C; Annoni A; Passerini L; Gregori S
J Autoimmun; 2023 Jul; 138():103051. PubMed ID: 37224733
[TBL] [Abstract][Full Text] [Related]
5. Engineered T Regulatory Type 1 Cells for Clinical Application.
Gregori S; Roncarolo MG
Front Immunol; 2018; 9():233. PubMed ID: 29497421
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10).
Comi M; Avancini D; Santoni de Sio F; Villa M; Uyeda MJ; Floris M; Tomasoni D; Bulfone A; Roncarolo MG; Gregori S
Cell Mol Immunol; 2020 Jan; 17(1):95-107. PubMed ID: 30842629
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance.
Castenmiller C; Keumatio-Doungtsop BC; van Ree R; de Jong EC; van Kooyk Y
Front Immunol; 2021; 12():643240. PubMed ID: 33679806
[TBL] [Abstract][Full Text] [Related]
10. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
11. IL-10-Modulated Human Dendritic Cells for Clinical Use: Identification of a Stable and Migratory Subset with Improved Tolerogenic Activity.
Kryczanowsky F; Raker V; Graulich E; Domogalla MP; Steinbrink K
J Immunol; 2016 Nov; 197(9):3607-3617. PubMed ID: 27683749
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
[TBL] [Abstract][Full Text] [Related]
13. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC.
Boks MA; Kager-Groenland JR; Haasjes MS; Zwaginga JJ; van Ham SM; ten Brinke A
Clin Immunol; 2012 Mar; 142(3):332-42. PubMed ID: 22225835
[TBL] [Abstract][Full Text] [Related]
14. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
Gregori S; Magnani CF; Roncarolo MG
Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
[TBL] [Abstract][Full Text] [Related]
15. Modulation of dendritic cell by pathogen antigens: Where do we stand?
Peron G; de Lima Thomaz L; Camargo da Rosa L; Thomé R; Cardoso Verinaud LM
Immunol Lett; 2018 Apr; 196():91-102. PubMed ID: 29427742
[TBL] [Abstract][Full Text] [Related]
16. Generation of Donor-specific T Regulatory Type 1 Cells From Patients on Dialysis for Cell Therapy After Kidney Transplantation.
Petrelli A; Tresoldi E; Mfarrej BG; Paganelli A; Spotti D; Caldara R; Secchi A; Battaglia M
Transplantation; 2015 Aug; 99(8):1582-9. PubMed ID: 25989499
[TBL] [Abstract][Full Text] [Related]
17. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells.
Volchenkov R; Karlsen M; Jonsson R; Appel S
Scand J Immunol; 2013 Apr; 77(4):246-54. PubMed ID: 23442246
[TBL] [Abstract][Full Text] [Related]
18. Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules.
Švajger U; Rožman PJ
Int Immunopharmacol; 2020 Apr; 81():106275. PubMed ID: 32044665
[TBL] [Abstract][Full Text] [Related]
19. Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer.
Comi M; Amodio G; Passeri L; Fortunato M; Santoni de Sio FR; Andolfi G; Kajaste-Rudnitski A; Russo F; Cesana L; Gregori S
Front Immunol; 2020; 11():1260. PubMed ID: 32695103
[TBL] [Abstract][Full Text] [Related]
20. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
